Preparing Avobis Bio for Partner Conversations Before the Phase II Readout

How building one coherent external story helped a clinical-stage cell therapy company enter the right rooms with the right preparation.

Industry

Health Tech

Goal

Investor & Partner Engagement

Solution

Brand Strategy + Website Development

Client

Avobis Bio

Avobis Bio was a clinical-stage cell therapy company approaching partner and investor conversations with strong science and an external presence that hadn't caught up. Eight months before their Phase II primary analysis, we built the story that let those conversations start from a position of credibility.

The Objectives

Avobis Bio had real scientific depth: a Phase II randomized trial underway, Fast Track Designation from the FDA, and a mechanism with genuine clinical differentiation. What they lacked was an external presence that made all of that immediately legible to partners and investors encountering the company for the first time.The risk: walking into high-stakes conversations with a story that required too much interpretation, at exactly the moment when clarity mattered most.

Our Approach

Working with Stellar Biotech, I led the brand messaging strategy: clarifying value propositions across audiences, building a verbal identity that balanced scientific depth with human accessibility, and creating a website that could do the work of a first conversation before anyone picked up the phone.

Team Work Made the Dream Work

“Knowing the expertise you brought [...] helped us align and feel confident moving forward together.”

Steve Alston, PhD; Product Development Leader at Avobis Bio

Step 1: Craft A Powerful Brand Messaging

Challenging
Assumptions

We encouraged the Avobis Bio team to define their core audiences' needs and deeply examine their messaging.

Clarifying Value Propositions

Through an iterative and collaborative process, we crafted succinct and audience-focused value propositions.

Shifting to
Storytelling

We simplified how they describe their technology, moving from technical jargon to a value-based approach.

“Our work on the website and strategy has better equipped me to create a pitch deck focused on storytelling over purely scientific slide decks.”

Tiffany Brown,PhD; CEO at Avobis Bio

Step 2: Humanize Science

“We all had a visceral reaction to the first mock-up - like, "Wow, that’s it!’”."

Stellar Biotech's initial mock-ups connected instantly with the Avobis Bio team, setting the tone for the brand direction.

The “Facing Forward” concept became a key design element, emphasizing the human impact of Avobis Bio’s mission.

The final website instilled a sense of legitimacy and readiness for new opportunities.

Immediate Outcome. Long Term Impact

“Potential partners came to the table with a clear understanding of who we are and what we do, allowing us to quickly dive into the conversations.”

At launch, the Avobis Bio team reported that potential collaborators arrived at conversations already oriented to the company's identity and mission. The external presence removed the friction of having to start from zero. Eight months later, STOMP-II primary analysis was complete, leading to an FDA RMAT designation request and an expanded fundraising story.

Conclusion

Our collaborative approach helped Avobis Bio align on messaging and build confidence as a team.

By aligning Avobis Bio’s internal values with an engaging external presence, we successfully prepared them for the next phase of growth—ready to connect, inspire, and thrive.

Ready to improve your brand and digital presence?

Over the last decade, we have developed brand strategy, pitch decks and content for healthcare, life science, medical device companies –big and small. Learn more about how we can help you deeply connect with your audiences and reach your KPIs faster.

Start Here